Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Awowale

Orthopaedic Surgery Green Bay, WI Medical Doctor

NPI 1649615329 CMS profile 3177282

1110 Kepler Dr, Green Bay, WI 54311

Open in the dashboard

General payments

$25,650

127 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Awowale of Green Bay, WI is reported in the CMS Open Payments database as having received $25,650 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $223 4
2024 General $183 3
2023 General $1,718 23
2022 General $3,612 25
2021 General $865 7
2020 General $3,843 17
2019 General $15,206 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Awowale
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to John Awowale were reported at $223. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year John Awowale Orthopaedic Surgery median Middle half National median
2019 $15,206 $644 $140–$2,844 $163
2020 $3,843 $312 $75–$1,860 $114
2021 $865 $520 $117–$2,495 $132
2022 $3,612 $598 $128–$2,731 $149
2023 $1,718 $461 $128–$2,264 $160
2024 $183 $497 $134–$2,475 $164
2025 $223 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $8,209 54 payments
  2. Great Lakes Orthopedics $6,370 20 payments
  3. Supreme Orthopedic Systems, LLC $4,272 2 payments
  4. Stryker Corporation $3,321 24 payments
  5. True North Surgical Inc $1,688 5 payments
  6. Smith+Nephew, Inc. $1,041 8 payments
  7. Zimmer Biomet Holdings, Inc. $526 7 payments
  8. DePuy Synthes Sales Inc. $204 6 payments
  9. Flexion Therapeutics, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $13,395 10 payments
  2. Travel and Lodging $8,073 24 payments
  3. Food and Beverage $4,182 93 payments
Products named General payments · program years 2019–2025
  1. HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET $2,034 7 payments
  2. SPEEDLOCK HIP $810 3 payments
  3. ACCUPASS DIRECT Crescent XL $732 3 payments
  4. Q-Fix $703 2 payments
  5. CINCHLOCK SS $633 8 payments
  6. Bioraptor Knotless $490 1 payment
  7. MICRORAPTOR Knotless Anchor $490 1 payment
  8. Suturefix $247 3 payments
  9. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $230 3 payments
  10. Bioraptor $213 1 payment
  11. Other $1,413 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

568

Median for Orthopedic Surgery: 203

Drug cost

$5,327

Median for Orthopedic Surgery: $1,433

Branded share of claims

8.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 42 $1,725
Celecoxib Generic 59 $1,364
Gabapentin Generic 115 $894
Meloxicam Generic 209 $601
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 50 $375
Methylprednisolone Generic 20 $151
Amoxicillin Generic 43 $115
Tramadol Hcl Generic 19 $60
Tizanidine Hcl Generic 11 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$71,270

Of which drugs: $2,984

Medicare patients

295

Average age 72

Services billed

1,440

183 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 35%
Diabetes 28%
Ischemic heart disease 28%
Chronic kidney disease 28%
Heart failure 19%
Atrial fibrillation 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 67 420 $284

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record